Authors:
Wielockx, B
Hochepied, T
Staelens, J
Van Molle, W
Brouckaert, P
Libert, C
Citation: B. Wielockx et al., Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor, CYTOKINE, 15(2), 2001, pp. 59-65
Authors:
Dick, JMC
Van Molle, W
Libert, C
Lefebvre, RA
Citation: Jmc. Dick et al., Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus, BR J PHARM, 134(2), 2001, pp. 425-433
Authors:
Hochepied, T
Van Molle, W
Berger, FG
Baumann, H
Libert, C
Citation: T. Hochepied et al., Involvement of the acute phase protein alpha(1)-acid glycoprotein in nonspecific resistance to a lethal Gram-negative infection, J BIOL CHEM, 275(20), 2000, pp. 14903-14909
Authors:
Van Molle, W
Hochepied, T
Brouckaert, P
Libert, C
Citation: W. Van Molle et al., The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis, INFEC IMMUN, 68(9), 2000, pp. 5026-5029
Authors:
Van Molle, W
Vanden Berghe, J
Brouckaert, P
Libert, C
Citation: W. Van Molle et al., Tumor necrosis factor-induced lethal hepatitis: pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH, FEBS LETTER, 467(2-3), 2000, pp. 201-205
Authors:
Van Molle, W
Denecker, G
Rodriguez, I
Brouckaert, P
Vandenabeele, P
Libert, C
Citation: W. Van Molle et al., Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins, J IMMUNOL, 163(10), 1999, pp. 5235-5241